Home
1
News
2
最新消息
3
[2025/07] Exhibition announcement－ LYNTONIX promoted LTX-568 in 2025 BIO Aisa4
https://www.lyntonix.com/en/ LYNTONIX, INC.
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan
Lyntonix officially joined ITRI’s Biomedical Accelerator on Sep. 14, 2026. By leveraging the accelerator’s industry resources and professional networking platform, Lyntonix aims to further strengthen its connections with industry partners, prospective collaborators, and professionals across various areas of business operations, thereby creating broader opportunities for strategic collaboration and business development. https://www.lyntonix.com/en/hot_540088.html [2026/09] News－Lyntonix Joins ITRI’s Biomedical Accelerator to Strengthen Industry Partnerships and Expand Collaboration Opportunities 2026-10-05 2027-10-05
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan https://www.lyntonix.com/en/hot_540088.html
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan https://www.lyntonix.com/en/hot_540088.html
https://schema.org/EventMovedOnline https://schema.org/OfflineEventAttendanceMode
2026-10-05 http://schema.org/InStock TWD 0 https://www.lyntonix.com/en/hot_540088.html
News
Home News 最新消息 [2025/07] Exhibition announcement－ LYNTONIX promoted LTX-568 in 2025 BIO Aisa

LYNTONIX attended 2025 BIO Asia and showcased the latest research data on LTX-568. During the convention, LTX-568 received strong interest and highly positive feedback from industry experts and partners. The next step for LTX-568 is to complete the GLP preclinical studies, and advance to clinical trials. Our mission is clear：Let the IBS patients regain control of their lives. LYNTONIX will keep focusing on the effective and safe thetreatment of IBS abdominal pain.


Previous Back to List Next